BioSpherix Medical

In 2014, BioSpherix Medical was established to accommodate the demand for equipment for clinical grade cell research and cell/gene therapies.

[BioSpherix Medical @BioSpherixMD]

Join us at ASME's free webinar to discuss exciting advancements in biomedical innovation! Register now: https://t.co/xHBsTGChjg

[BioSpherix, LLC @BioSpherix]

Have your cell cultures been naughty this year, or nice?
Happy Holidays, from the BioSpherix family.

[BioSpherix Medical @BioSpherixMD]

How do we measure parameters for biofabricated tissues? What critical aspects of tissue engineered products remain unmonitored? Join us Dec 1st at NIST's virtual workshop to discuss measurement needs, future directions, and more.

https://t.co/LlOEi3pMqG

[Phase Holographic Imaging @PhaseHolo]

We are so thrilled to share this news!
https://t.co/9dgsmu1ZIc

#regenerativemedicine #biomanufacturing #celltherapies #holomonitor @BioSpherix @QIAGEN @WFIRMnews @SASsoftware

[BioSpherix Medical @BioSpherixMD]

Closed systems are the future of scalable cell and gene therapy.

Read more (open access): https://t.co/bBSAiiXRPv

#Cytocentric #Regenmed #Genetherapy #hypoxia #physioxia #cGMP

[BioSpherix, LLC @BioSpherix]

Relevant miRNA patterns under pathophysioxia:
Majewska et al. study the role of PTEN in kidney cancer by mimicking the TME in vitro.

Read more (open access): https://t.co/l79pZQQIzX

#Cytocentric #Cellculture #hypoxia #physioxia #TME #miRNA #PTEN

[BioSpherix, LLC @BioSpherix]

Culture Oxygen Drives MSC Metabolism: Olesen et al. discuss respiration and metabolic adaptation to low oxygen tension in mesenchymal stromal cells.
Read more (open access): https://t.co/pNfjxOjVAy
#Cytocentric #MSC #Hypoxia #Physioxia

[BioSpherix Medical @BioSpherixMD]

Congratulations to Emma Warner, who finished her Summer Scholar project successfully in the Xvivo System at WFIRM with the help of the incredible Katie Benson! @WFIRMnews

#Cytocentric #CellCulture #RegenMed

[BioSpherix Medical @BioSpherixMD]

Li et al. discuss the potential use of low oxygen to pre-activate therapeutic MSCs.
Read more: https://t.co/9BJcIZDTs8

#MSC #hypoxia #physioxia #cellculture #celltherapy

[BioSpherix Medical @BioSpherixMD]

BioSpherix is at #ISSCR2022! Join us at Booth 205 for the latest on equipment that meets the needs of #StemCells. Then, check out poster #516 : Increasing Human MSC Yields Through Unbroken Physioxia.

https://t.co/J6GRLF3EkL
https://t.co/RVhKLzHQdX

#Cytocentric #Cellculture

[BioSpherix Medical @BioSpherixMD]

June 8th, from 12:45 to 2:05, BioSpherix CEO Randy Yerden will share concepts on building facilities that prioritize the needs of cells. Join us!

https://t.co/UuqwwHzPA0
https://t.co/bw32Y1MtKl

#WSCS22 #StemCell #Cytocentric #CellCulture

[BioSpherix Medical @BioSpherixMD]

Herbemont et al. find that culturing human embryos under physiologic O2 at the cleavage stage improves embryo quality and development potential.

Read more (open access): https://t.co/4710qVb2CN

#IVF #Hypoxia #Embryo #Physioxia #Cytocentric #Cell

[BioSpherix Medical @BioSpherixMD]

On this International Day of Women and Girls in Science, we're celebrating the members of our amazing lab team, current and former! #STEM #WomeninStem

[BioSpherix Medical @BioSpherixMD]

The revolution will be enclosed: Abraham et al. of @LonzaGroup assert that the next step towards commercial-scale autologous cell therapy manufacturing is closed, automated, and scalable platforms.
Read more https://t.co/lzfOkWtNVB

[BioSpherix Medical @BioSpherixMD]

Egger et al. of @BOKUvienna review MSC therapies, find that physiologic O2 is key to improved therapeutic properties, and call for the use of physioxia during MSC isolation and expansion.

Read more: https://t.co/fwq6eV01cQ

#hypoxia #celltherapy #MSC #physioxia #oxygen #GMP

[J. Am. Chem. Soc. @J_A_C_S]

Anticancer Agent with Inexplicable Potency in Extreme Hypoxia: Characterizing a Light-Triggered Ruthenium Ubertoxin @utarlington #Anticancer #Hypoxia #Lightriggered #Ubertoxin #Ruthenium https://t.co/DM9DVT2l8G

[The Hospital Research Foundation Group @hosp_research]

Adelaide will be the leading centre of excellence in the southern hemisphere for the treatment of chronic #pancreatitis with a purpose-built facility officially opened today!
A #BiospherixChamber has been purchased thanks to a $1.4M grant from THRF Group!
https://t.co/6s0DidX9Ca

[BioSpherix, LLC @BioSpherix]

O'Reilly et al. of @ResearchatNUIG use hypoxia to mimic the bone marrow environment, inducing quiescence in vitro in treatment-resistant leukemic cells. Congratulations @Eim_OReilly @EvaSzegezdi @SteBioCat !

Read more (open acc): https://t.co/IMFlbwJxum

#Cytocentric #invitro

[BioSpherix, LLC @BioSpherix]

Are those tox results relevant? Mennen et al. report that the ESTc behaves differently in physioxia than it does in room air O2.

Read more: https://t.co/m3Jo0l4Zk1

#EST #ESTc #Oxygen #Hypoxia #Toxicity #Development

[BioSpherix, LLC @BioSpherix]

What does #MSC stand for? Wrong answers only.

Then, read up on MSCs and regenerative medicine on the Cytocentric Blog: https://t.co/sGq6GYALeb

#Celltherapy #hypoxia #cytocentric #cellculture #invitro